As of 2025-05-27, the Net Margin of VIVA Biotech Holdings (1873.HK) is 8.4%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 8.4% |
2023-12-31 | -5.4% |
2022-12-31 | -22.2% |
2021-12-31 | 13.7% |
2020-12-31 | -55.5% |
2019-12-31 | 82.3% |
2018-12-31 | 43.1% |
2017-12-31 | 51.4% |
2016-12-31 | 25.4% |
- |